Barcelona Boston Lung Conference – 11ª Edición
febrero 12, 2024
El 23 y 24 de febrero de 2024 se celebra la 11ª Edición Barcelona Boston Lung Conference. Presentación de 12 abstracts de entre todos los abstracts recibidos.
El 23 y 24 de febrero de 2024 se celebra la 11ª Edición Barcelona Boston Lung Conference. Presentación de 12 abstracts de entre todos los abstracts recibidos.
The GOLD 2023 report identifies different causes (etiotypes) of COPD. Their prevalence in individuals in the general population with persistent airflow obstruction (PAO) is unknown.
In this expert interview, MeiLan K Han and Alvar Agustí discuss the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 executive report, which proposes a new definition for COPD and covers the latest updates in its diagnosis, management, and prevention.
Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous outcomes, often omitting those that are clinically relevant or more important to patients. (…)
Un año después de su presentación en sociedad, el programa ANTES está en pleno desarrollo. En línea con sus objetivos iniciales, muy recientemente se ha publicado un artículo especial enfatizando la importancia de realizar ensayos clínicos de intervención en pacientes jóvenes con EPOC o pre-EPOC19. .
Chronic obstructive pulmonary disease (COPD) is the end result of a series of dynamic and cumulative gene-environment interactions over a lifetime…
The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia